EDGAR Filing Documents for 0001193125-11-163140

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-11-163140

Filing Date

2011-06-13

Accepted

2011-06-10 17:48:58

Documents

Period of Report

2011-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	2401643
2	LIST OF SUBSIDIARIES	dex21.htm	EX-21	2481
3	CONSENT OF BDO USA, LLP	dex231.htm	EX-23.1	2594
4	CONSENT OF KPMG LLP	dex232.htm	EX-23.2	3091
5	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)	dex311.htm	EX-31.1	9254
6	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)	dex312.htm	EX-31.2	9240
7	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	5202
8	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	5159
9	GRAPHIC	g196003g89z34.jpg	GRAPHIC	65054
	Complete submission text file	0001193125-11-163140.txt		2529429

Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044

Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600

KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)